COVIRUPT

Welcome to the Brand page for “COVIRUPT”, which is offered here for Medicines for the treatment of viral infections; pharmaceutical preparations for the treatment of viral infections; pharmaceutical preparations in the form of aqueous solution, inhalation solution, and injectable solutions for use in the treatment of viral infections; pharmaceuticals in the form of medicated creams, lotions, and ointments for dermatological use; preparations against infectious agents, disinfectants; sanitary preparations for medical and veterinary purposes; medicated virucidal mouth and throat washes; medicated products for the treatment of viral infections, mouth and throat sprays, nasal sprays, nasal oils, nasal ointments, nasal creams and nasal drops for medical and veterinary purposes; medicated lozenges for medical purposes; skin disinfectant; medicated skin care preparations; antiseptic wipes for medical, veterinary and surgical purposes; disinfectants; wipes and medical dressings impregnated with disinfectants or virucidal pharmaceutical solutions; disinfecting biochemical and biological preparations for medical and veterinary purposes; virucides for medical or veterinary purposes; polypeptides, nucleic acids, proteins, lipids, enzymes and enzyme preparations for medical, veterinary and disinfection purposes; medicated eye washes, medicated eye drops and additives for medicated eye washes and medicated eye drops; animal feed additives for treating infectious diseases; germicides; cleansing preparations with disinfecting effect for hygienic purposes; medicated animal and livestock washes;biochemical and biological preparations and reagents for commercial, industrial, scientific and laboratory use, other than for medical or veterinary purposes; biochemical and biological preparations and reagents for research and development in the fields of human and veterinary medicine, pharmacy, biology and biotechnology; industrial detergence for use in manufacturing processes; detergence for use in industrial manufacturing processes; active biochemical and biological ingredients for use in the manufacture of pharmaceutical preparations for treating viruses; active biochemical and biological additives for use in the manufacture of medical dressings; biochemical and biological additives for use in the manufacture of medicine, pharmaceutical preparations, medical dressings and plasters, personal care products and sanitary products; biochemical and biological additives and active biochemical and biological ingredients for use in the manufacture of medicines and pharmaceuticals for treating viral infections, medical dressings and plasters, personal care products and sanitary products; biochemical and biological preparations, for use in the manufacture of pharmaceuticals for treating viral infections; biochemical and biological raw materials for use as active ingredients in the manufacture of pharmaceutical preparations for treating viral infections; biochemical and biological preparations having antimicrobial and/or virucidal properties, other than for medical or veterinary purposes; biological, biochemical and biotechnological substances for use as additives in the manufacture of personal care products;scientific research in the field of pharmaceuticals; research and development services and research work in the fields of medicine, pharmacy, bacteriology, virology, health products, cosmetics and food supplements; research and development consultancy, in particular in the fields of medicine, pharmacy, bacteriology, virology, health products, cosmetics and food supplements; industrial analytical and research services, in particular in the fields of antimicrobial and virucidal analysis and research;.

Its status is currently believed to be active. Its class is unavailable. “COVIRUPT” is believed to be currently owned by “LYSANDO AG”.